News and Media

Latest News Release
11/11/2024

Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health announces redemption of outstanding notes
08/13/2021

DUBLIN, Ohio, Aug. 13, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it is sending an irrevocable notice of early redemption to the holders of all of the Company's 2.616% notes due June 2022 that are outstanding as of the early redemption date (aggregate principal amount of $572,171,000). The early redemption date is set to September 15, 2021, pursuant to the June 2, 2008 indenture and the 2.616% notes.

With respect to the 2.616% notes, in accordance with the terms and conditions set forth in the indenture and the 2.616% notes, the 2.616% notes will be redeemed at a redemption price equal to the greater of (i) 100% of the principal amount of the notes to be redeemed or (ii) the sum of the present values of the remaining scheduled payments of principal and interest on the notes to be redeemed that would be due if the notes of such series matured on May 15, 2022 (exclusive of interest accrued to the date of redemption) discounted to the date of redemption on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the Adjusted Treasury Rate (as defined in the 2.616% notes) plus 15 basis points, plus, in either case, accrued and unpaid interest on the amount of the 2.616% notes being redeemed to, but excluding, the date of redemption.

This press release shall not constitute a notice of redemption of the 2.616% notes, and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 40 countries and approximately 48,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.

Cardinal Health uses its website as a channel of distribution for material company information. Important information, including news releases, financial information, earnings and analyst presentations, and information about upcoming presentations and events is routinely posted and accessible on the Investor Relations page at ir.cardinalhealth.com. In addition, the website allows investors and other interested persons to sign up automatically to receive email alerts when the company posts news releases, SEC filings and certain other information on its website.

Cautions concerning forward-looking statements
This release contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results or guidance, statements of outlook and various accruals and estimates. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include, but are not limited to, volatility or disruption in the debt capital markets. Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. This release reflects management's views as of August 13, 2021. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement.

Media Contact:
Andrew Stern
614-339-4678
andrew.stern@cardinalhealth.com

Investor Contact:
Kevin Moran
614-757-7942
kevin.moran@cardinalhealth.com

SOURCE Cardinal Health

More Company News
12/20/2024

Cardinal Health poised to become the first company to offer cGMP-compliant material at commercial scale by year end DUBLIN, Ohio, Dec. 20, 2024 – Cardinal Health (NYSE: CAH) today announced the...

12/19/2024

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2025 on January 30, prior to the opening of trading on the New York Stock Exchange. The company...

12/03/2024

ION accelerates development of Navista, integrating more than 100 providers at more than 50 community-based sites across 10 states into oncology practice alliance. DUBLIN, Ohio, Dec. 3, 2024 –...

11/20/2024

Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio, Nov. 20, 2024 /PRNewswire/ -- Cardinal Health...

View all company news »